Dive in and do the best work of your career at DigitalOcean. Journey alongside a strong community of top talent who are relentless in their drive to build the simplest scalable cloud. If you have a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The Field Medical Outcomes Director is a field-based medical colleague responsible for providing therapeutic area/product expertise for a designated therapeutic in Oncology, with a primary focus on integrated customers, including but not limited to National Payers,